文献速递乳腺癌放疗放疗物理与技术

乳腺杯固定装置对放疗美容与疼痛患者报告结局的影响

The Use of Breast Cup Immobilization in Radiation Therapy and Patient-Reported Outcomes on Cosmesis and Pain.
PubMed 文献 · Adv Radiat Oncol · 2025-03-17

该回顾性分析纳入2011至2019年645例接受辅助乳腺放疗的患者,其中79例使用乳腺杯固定。与未使用乳腺杯者相比,乳腺杯组在治疗期间、治疗后1个月及1年时患者报告的美容与疼痛结局无显著差异,除治疗后1个月淋巴水肿外。左乳癌患者使用乳腺杯的平均心脏剂量更低。

要点

  • 乳腺杯组与未使用组在治疗期间、治疗后1个月及1年时皮肤瘙痒、质地改变及乳腺疼痛的P值均无统计学显著性。
  • 左乳癌患者使用乳腺杯的总体平均心脏剂量更低。

核心结论

  • 从患者角度看,放疗期间使用乳腺杯与未使用相比未对乳腺美容或疼痛产生负面影响。
  • 左乳癌患者使用乳腺杯的总体平均心脏剂量更低。

研究设计与样本

  • 回顾性分析2011至2019年645例接受辅助乳腺放疗的患者,其中79例使用乳腺杯。
  • 通过Michigan Radiation Oncology Quality Consortium数据库收集患者报告结局,包括治疗期间、治疗后1个月及1年时。
  • 采用逻辑回归分析比较两组皮肤改变、淋巴水肿和乳腺疼痛的差异,并分析两组平均心脏剂量。

主要发现

  • 乳腺杯组治疗期间、治疗后1个月及1年时2级治疗侧乳腺瘙痒报告率分别为49.4%、35.4%、22.8%,与未使用组相比各时间点P值均无统计学显著性。
  • 乳腺杯组治疗期间、治疗后1个月及1年时乳腺疼痛报告率分别为36.7%、15.2%、11.4%,各时间点P值均无统计学显著性。
  • 除治疗后1个月患者报告的淋巴水肿外,两组副作用比较均无统计学显著性。

临床怎么用

  • 对于接受辅助乳腺放疗的患者,可考虑使用乳腺杯固定装置,因其未对患者报告的美容或疼痛结局产生负面影响。
  • 对于左乳癌患者,使用乳腺杯可能与更低的平均心脏剂量相关。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Breast cosmesis and breast pain are among the most reported outcomes in patients undergoing adjuvant breast irradiation. The degree to which such adverse reactions occur can be variable based on different patient-specific characteristics. It has been found that women with a larger body habitus, and larger breasts, tend to have an increased chance of experiencing worse toxicity from treatment. As such, attempts to improve cosmetic and pain outcomes have been a highly explored topic. One such technique, that is studied here, is to explore whether the use of a breast cup during treatment leads to worse breast pain and cosmetic outcomes when compared with those treated without a breast cup. This proves to be an important topic because it is believed that the use of a breast cup would provide a significant dosimetric advantage (ie, breast coverage and organ at risk dosing) during treatment. We now explore this treatment option through the scope of a retrospective analysis of patient-reported outcomes experienced during and after completing postoperative radiation therapy to the breast. METHODS AND MATERIALS: A total of 645 patients undergoing adjuvant breast irradiation were evaluated from 2011 to 2019. Of the 645 patients, 79 were treated using a breast cup. The mean heart dose was analyzed and compared between the 2 treatment groups. Additionally, patient-reported outcomes among the entire cohort were collected via survey documentation forms during treatment, at 1 month after the completion of treatment, and at 1 year after the completion of treatment. These results were collected using the Michigan Radiation Oncology Quality Consortium database because each patient was consented to enroll in the Michigan Radiation Oncology Quality Consortium prior to starting treatment. The outcomes of skin changes, lymphedema, and breast pain among the 2 treatment groups were then compared for statistically significant differences via a logistic regression analysis. RESULTS: Of the 79 patients treated with a breast cup, grade 2 pruritus of the treated breast along with grade 1 alteration in skin texture was reported in 49.4%, 35.4%, and 22.8% while on treatment, at 1 month after the completion of treatment, and at 1 year after treatment, respectively; P-values were nonsignificant at all timepoints when data compared with non-cup-treated patients. With regard to lymphedema, 59.5%, 40.5%, and 10.1% of breast cup patients at the prespecified timepoints reported this sequela; all P-values were nonsignificant except for the 1-month mark (P-value .03). Lastly, breast pain was noted in 36.7%, 15.2%, and 11.4% of breast cup-treated patients while on treatment, at 1 month after the completion of treatment, and at 1 year after treatment, respectively; again, P-values for data analysis at each timepoint were nonsignificant. Other than the patient-reported outcome of lymphedema 1 month after the completion of treatment, no statistical significance was seen in comparing side effects between the 2 treatment arms. CONCLUSIONS: From our patients' perspective, the use of a breast cup during radiation therapy did not negatively impact breast cosmesis or pain when compared with patients treated without a cup. Furthermore, breast cup use was also found to produce a lower overall mean heart dose in patients with left-sided breast cancer.

来源:Adv Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Chapman D, Matsumoto A, Aldridge K, et al. The Use of Breast Cup Immobilization in Radiation Therapy and Patient-Reported Outcomes on Cosmesis and Pain. Adv Radiat Oncol. 2025. PMID: 40276628. doi:10.1016/j.adro.2025.101759

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。